跳至主要内容
临床试验/NCT02902757
NCT02902757已完成不适用

Very Early Response Monitoring in Patients With Glioblastoma Undergoing Therapy Using FDG PET/CT

Jonsson Comprehensive Cancer Center2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2015年8月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
7
试验地点
2
主要终点
Changes in glucose uptake

研究概览

简要总结

This pilot clinical trial studies fluordeoxyglucose (fludeoxyglucose) F-18 (FDG) positron emission tomography (PET)/computed tomography (CT) in monitoring very early therapy response in patients with glioblastoma. Diagnostic procedures, such as FDG PET/CT, may help measure a patient's response to earlier treatment. Chemotherapy can induce very rapid changes to the tumor's glucose consumption which can be measured with imaging. FDG PET/CT shortly after the start of therapy may help identify very early therapy response in patients with glioblastoma.

详细描述

PRIMARY OBJECTIVES:

I. To assess very early response to therapy in glioblastoma patients using 18F-FDG PET/CT.

II. Evaluate very early changes in FDG uptake within 48 hours of start of therapy and correlate them with objective response parameters such as Response Assessment in Neuro-Oncology (RANO) and survival.

OUTLINE:

Patients undergo standard FDG PET/CT scan 6-8 weeks before start of chemotherapy and one additional FDG PET/CT scan within 48 hours of the start of chemotherapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with histologically proven high grade glioma
  • Intention to start therapy

排除标准

  • Severe psychiatric illness
  • Inability to give written consent
  • Breast feeding / pregnancy

研究组 & 干预措施

Treatment (FDG PET/CT)

Experimental

Patients undergo standard FDG PET/CT scan 6-8 weeks before start of chemotherapy and one additional FDG PET/CT scan within 48 hours of the start of chemotherapy.

干预措施: Computed Tomography (Procedure)

Treatment (FDG PET/CT)

Experimental

Patients undergo standard FDG PET/CT scan 6-8 weeks before start of chemotherapy and one additional FDG PET/CT scan within 48 hours of the start of chemotherapy.

干预措施: Positron Emission Tomography (Procedure)

结局指标

主要结局

Changes in glucose uptake

时间窗: From baseline up to 48 hours

Standardized uptake values (SUV) will be calculated for different organs and for regions of tumor. Further, regional target to background count-activity ratios will be established.

Very early changes in tumor glucose uptake predictive for objective treatments response and survival assessed using RANO criteria

时间窗: One PET/CT 48 hours after start of therapy

SUV will be calculated for different organs and for regions of tumor. Further, regional target to background count-activity ratios will be established.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验